Jessica E. Hoogendijk is a neurologist at the University Medical Center Utrecht. She co-organised the national continuing education program on neuromuscular disorders for general neurologists. As an awarded qualified medical teacher, she enjoys guiding residents and fellows at the ERN-certified centre of expertise for neuromuscular disorders in Utrecht. Marianne de Visser is an adult neurologist and emeritus Professor of Neuromuscular Diseases at the Amsterdam University Medical Center. Her research interests areALS, myositis, hereditary neuropathies. Pieter A. van Doorn is a neurologist and Professor of Neuromuscular Diseases at Erasmus MC in Rotterdam. His research interests are immune-mediated neuropathies, epidemiology of polyneuropathy, Pompe disease. He was president of the Peripheral Nerve Society (PNS), and chaired/co-chaired the EAN/PNS Guidelines on GBS and CIDP. Erik H. Niks is a paediatric and adult neurologist at the Leiden University Medical Center with a focus on multidisciplinary care in paediatric neuromuscular diseases. He received a teaching award from the Netherlands Society of Neurology.

• Part I. Evaluation and Treatment of Patients with a Neuromuscular Disorder: 1. Neuromuscular diseases: anterior horn cell disorders, peripheral neuropathies, neuromuscular junction disorders, myopathies; 2. History taking and clinical examination; 3. Differential diagnosis by presenting or prominent clinical feature; 4. Electrodiagnostic studies; 5. Imaging; 6. Muscle and nerve pathology; 7. Genetic testing; 8. Management; Part II. Neuromuscular Cases; Disorders of the Anterior Horn Cell: 1. Amyotrophic lateral sclerosis; 2. Primary lateral sclerosis, 3. Progressive muscular atrophy); 4. Segmental spinal muscular atrophy; 5. Spinal and bulbar muscular atrophy (SBMA; Kennedy disease); 6. Spinal muscular atrophy type I; 7. Spinal muscular atrophy type 3; 8. Post-polio syndrome; poliomyelitis anterior acuta, West Nile virus poliomyelitis, acute flaccid weakness in children; Peripheral Neuropathies: 9. Guillain-Barré syndrome and Miller-Fisher syndrome; 10. Chronic inflammatory demyelinating polyneuropathy; 11. IgM anti-MAG polyneuropathy; 12. Polyneuropathy, organomegaly, endocrine manifestations, monoclonal protein, and skin changes syndrome; 13. Vasculitic neuropathy; 14. Small fibre neuropathy; 15. Paraneoplastic sensory neuronopathy (SNN, ganglionopathy); 16. Wartenberg migrant sensory neuropathy; 17. Multifocal motor neuropathy; 18. Peripheral nerve hyperexcitability syndromes: Morvan syndrome; 19. Idiopathic brachial plexus neuropathy, neuralgic amyotrophy; 20. Diabetic polyneuropathy; 21. Alcoholic polyneuropathy; 22. Chronic idiopathic axonal polyneuropathy; 23. Critical illness polyneuropathy and myopathy; 24. Drug-induced polyneuropathies: Amiodarone polyneuropathy; 25. Lyme radiculopathy; 26. Leprosy; 27. Charcot-Marie-Tooth disease type 1a/Hereditary neuropathy with liability to pressure palsies; 28. Charcot-Marie-Tooth disease type 2a and 2b; 29. Hereditary sensory and autonomic neuropathy type 4; 30. Hereditary transthyretin amyloidosis; Disorders of the Neuromuscular Junction: 31. Myasthenia gravis with acetylcholine receptor antibodies; 32. Myasthenia gravis with MuSK antibodies; 33. Drug-induced myasthenia gravis: Immune checkpoint inhibitor-related; 34. Lambert-Eaton myasthenic syndrome; 35. Congenital myasthenic syndromes: Dok7; Myopathies: 36. Duchenne muscular dystrophy; 37. Becker muscular dystrophy; 38. Facioscapulohumeral muscular dystrophy; 39. Myotonic dystrophy type 1; 40. Myotonic dystrophy type 2; 41. Limb girdle muscular dystrophy R1, calpain-related; 42. Limb girdle muscular dystrophy R9, FKRP-related; 43. Bethlem myopathy, a collagen VI-related myopathy; Ullrich congenital muscular dystrophy; 44. Oculopharyngeal muscular dystrophy; 45. Emery-Dreifuss muscular dystrophy; 46. Caveolinopathy, rippling muscle disease; 47. Distal myopathies: Miyoshi myopathy, dysferlinopathy; anoctaminopathy; 48. Distal myopathies: GNE myopathy; 49. Myofibrillar myopathies: Desminopathy; 50. Skeletal muscle channelopathies: non-dystrophic myotonia; myotonia congenita (Becker); 51. Skeletal muscle channelopathies: hypokalaemic periodic paralysis; 52. Pompe Disease (glycogen storage disease type II; α-glucosidase deficiency); 53. McArdle Disease (glycogen storage disease type V); myophosphorylase deficiency), rhabdomyolysis; 54. Carnitine palmitoyltransferase-II deficiency; 55. Mitochondrial myopathies: chronic progressive external ophthalmoplegia; 56. Ryanodine receptor 1-related disorders; 57. Congenital myopathies: X-linked myotubular myopathy; 58. Congenital myopathies: nemaline myopathy; 59. Juvenile dermatomyositis; 60. Dermatomyositis; 61. Immune-mediated necrotising myopathy; 62. Inclusion body myositis; 63. Endocrine myopathy: Hypothyroid myopathy; hyperthyroid myopathy; 64. Drug-induced myopathies: hydroxychloroquine myopathy; 65. A- or paucisymptomatic hyperCKaemia; 66. Exertional rhabdomyolysis.